Camrese Lo and Dupilumab Subcutaneous
Determining the interaction of Camrese Lo and Dupilumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ethinyl estradiol / levonorgestrel
Brand name: Amethia, Amethia Lo, Camrese, Camrese Lo, Daysee, Introvale, Jolessa, LoSeasonique, Quartette, Quasense, Seasonale, Seasonique, Afirmelle, Altavera, Amethyst, Ashlyna, Aubra, Aubra EQ, Aviane, Ayuna, Balcoltra, Chateal, Chateal EQ, Delyla, Enpresse-28, FaLessa, Falmina, Fayosim, Kurvelo, Larissia, Lessina, Levonest, Levora 015/30, Lillow, Lutera, Marlissa, Myzilra, Orsythia, Portia-28, Rivelsa, Setlakin, Simpesse, Sronyx, Trivora, Vienva, Alesse, Enpresse, Levlen, Levora, Lybrel, Nordette, Portia, Tri-Levlen, Triphasil-21, Triphasil-28, Trivora-28, Preven EC, Triphasil
Synonyms: Camrese Lo (extended-cycle)
Generic Name: dupilumab
Brand name: Dupixent
Synonyms: Dupilumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Camrese Lo-Dupixent
- Camrese Lo-Duplex T Topical
- Camrese Lo-Durachol
- Camrese Lo-Duraclon
- Camrese Lo-Duraclon injection
- Camrese Lo-Duraflu
- Dupilumab Subcutaneous-Camrese Lo extended-cycle
- Dupilumab Subcutaneous-Canagliflozin
- Dupilumab Subcutaneous-Canagliflozin and metformin
- Dupilumab Subcutaneous-Canagliflozin and Metformin Extended-Release Tablets
- Dupilumab Subcutaneous-Canagliflozin and Metformin Tablets
- Dupilumab Subcutaneous-Canakinumab